MedPath

Evaluation of Some Biochemical Markers of Bone Turnover in Childern and Adolescents With Type 1 Diabetes

Not yet recruiting
Conditions
Type 1 Diabetes
Interventions
Diagnostic Test: serum ostecalcin,serum sclerostin and parathroid profile
Registration Number
NCT05892848
Lead Sponsor
Sohag University
Brief Summary

Type 1 diabetes is associated with many longterm complications as retinopathy,neuropathy and nephropathy. Recently, several studies have linked type 1 diabetes to bone fragility.Studies conducted on patients with type 1 diabetes have concluded that bone is negatively affected in type 1 diabetes with impaired bone density,increased fracture risk and impaired bone turnover markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • childern and adolsecents below 16 years of age diagnsed with type 1 diabetes for at least 1 year age and sex-matched control childern and adolsecents will be included
Read More
Exclusion Criteria
  • childern and adolescents with congenital bone disease, those with disorders of the parathyroid gland and those with chronic kidney disease.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control groupserum ostecalcin,serum sclerostin and parathroid profileage and sex matched control childern and adolsecents
cases groupserum ostecalcin,serum sclerostin and parathroid profilechildern and adolescents with type 1 diabetes
Primary Outcome Measures
NameTimeMethod
level of serum ostecalcin, sclerostin in patients with type 1 diabetes ann d their age and sex matched control12 months

markers of bone turnover in patients with type 1 diabetes and their matched control

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag university Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath